Cardiac Arrest Clinical Trials

Find Cardiac Arrest Clinical Trials Near You

The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether transferring participants to a hospital with a specialized cardiac arrest service improves recovery of function after 90 days. Participants will receive all usual medical care, but some participants will be offered transfer to a regional cardiac arrest center and others will be offered care at the closest appropriate hospital. Investigators will interview participants after 90 days to assess their recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Out-of-hospital cardiac arrest

• Resuscitated from cardiac arrest with palpable pulse in the emergency department

• Treated at one of participating hospital emergency departments

• Age ≥18 years

Locations
United States
Pennsylvania
University of Pittsburgh Department of Emergency Medicine
RECRUITING
Pittsburgh
Contact Information
Primary
Sara DiFiore-Sprouse
difioresm@upmc.edu
4128642284
Time Frame
Start Date: 2026-05-11
Estimated Completion Date: 2032-01
Participants
Target number of participants: 1618
Treatments
Experimental: Transfer to specialty care
Participants randomized to receive specialty care will undergo immediate interfacility transport to and hospital treatment at the specialty care hospital
Active_comparator: Usual care
Participants randomized to the usual care arm will be hospitalized at the first hospital or transferred to the closest appropriate hospital
Related Therapeutic Areas
Sponsors
Leads: University of Pittsburgh
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov